Roberts J, Foulkes A
William Mary Law Rev. 2023; 62(1):143-211.
PMID: 37654734
PMC: 10471136.
Sakaguchi T, Tokutomi T, Yoshida A, Yamamoto K, Obata K, Carrieri D
J Hum Genet. 2023; 68(8):551-557.
PMID: 37072622
DOI: 10.1038/s10038-023-01149-x.
Doheny S
Hum Genet. 2021; 141(5):1045-1051.
PMID: 34459979
PMC: 9160136.
DOI: 10.1007/s00439-021-02353-5.
Savatt J, Myers S
Front Pediatr. 2021; 9:526779.
PMID: 33681094
PMC: 7933797.
DOI: 10.3389/fped.2021.526779.
Carrieri D, Howard H, Benjamin C, Clarke A, Dheensa S, Doheny S
Eur J Hum Genet. 2018; 27(2):169-182.
PMID: 30310124
PMC: 6336881.
DOI: 10.1038/s41431-018-0285-1.
Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe.
Sirchia F, Carrieri D, Dheensa S, Benjamin C, Kayserili H, Cordier C
Eur J Hum Genet. 2018; 26(7):946-954.
PMID: 29681620
PMC: 6018700.
DOI: 10.1038/s41431-018-0131-5.
Physicians' duty to recontact and update genetic advice.
Stevens Y, Senner G, Marchant G
Per Med. 2017; 14(4):367-374.
PMID: 29158769
PMC: 5693364.
DOI: 10.2217/pme-2017-0012.
Beyond individualism: Is there a place for relational autonomy in clinical practice and research?.
Dove E, Kelly S, Lucivero F, Machirori M, Dheensa S, Prainsack B
Clin Ethics. 2017; 12(3):150-165.
PMID: 28989327
PMC: 5603969.
DOI: 10.1177/1477750917704156.
Ethical considerations in genomic testing for hematologic disorders.
Marron J, Joffe S
Blood. 2017; 130(4):460-465.
PMID: 28600340
PMC: 5533200.
DOI: 10.1182/blood-2017-01-734558.
The Genetic Counselor's Role in Managing Ethical Dilemmas Arising in the Laboratory Setting.
Balcom J, Kotzer K, Waltman L, Kemppainen J, Thomas B
J Genet Couns. 2016; 25(5):838-54.
PMID: 27103422
DOI: 10.1007/s10897-016-9957-6.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J
Genet Med. 2015; 17(5):405-24.
PMID: 25741868
PMC: 4544753.
DOI: 10.1038/gim.2015.30.
Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature.
Otten E, Plantinga M, Birnie E, Verkerk M, Lucassen A, Ranchor A
Genet Med. 2014; 17(8):668-78.
PMID: 25503495
DOI: 10.1038/gim.2014.173.
ACMG clinical laboratory standards for next-generation sequencing.
Rehm H, Bale S, Bayrak-Toydemir P, Berg J, Brown K, Deignan J
Genet Med. 2013; 15(9):733-47.
PMID: 23887774
PMC: 4098820.
DOI: 10.1038/gim.2013.92.
Communicating new knowledge on previously reported genetic variants.
Aronson S, Clark E, Varugheese M, Baxter S, Babb L, Rehm H
Genet Med. 2012; 14(8):713-719.
PMID: 22481129
PMC: 3841913.
DOI: 10.1038/gim.2012.19.
The legal risks of returning results of genomics research.
Clayton E, McGuire A
Genet Med. 2012; 14(4):473-7.
PMID: 22323070
PMC: 3779603.
DOI: 10.1038/gim.2012.10.
Patient preferences regarding recontact by cancer genetics clinicians.
Griffin C, Axilbund J, Codori A, Deise G, May B, Pendergrass C
Fam Cancer. 2007; 6(3):265-73.
PMID: 17308889
DOI: 10.1007/s10689-007-9117-0.
A survey of patients' experiences with the cancer genetic counseling process: recommendations for cancer genetics programs.
Kausmeyer D, Lengerich E, Kluhsman B, Morrone D, Harper G, Baker M
J Genet Couns. 2006; 15(6):409-31.
PMID: 17106634
DOI: 10.1007/s10897-006-9039-2.
